Contribution of HPV Status for Neutrophil Extracellular Traps Release in Oropharyngeal Cancer
- PMID: 39581629
- DOI: 10.1111/jop.13594
Contribution of HPV Status for Neutrophil Extracellular Traps Release in Oropharyngeal Cancer
Abstract
Background: Oropharyngeal squamous cell carcinoma (OP-SCC) represents a public health problem and human papillomavirus (HPV) is one of the risk factors. Neutrophil extracellular traps (NET) are meshes of DNA strands and granule proteins. NET has been identified in diverse cancers, whether associated with viruses or not. However, there is no information on NET in OP-SCC. We aimed to evaluate the NET release by neutrophils in the OP-SCC microenvironment, stratified by HPV status.
Methods: This cross-sectional study analyzed OP-SCC biopsy specimens diagnosed from 1997 to 2021. HPV status was determined by p16 immunohistochemistry and "in situ" hybridization. Neutrophils were detected by CD66b immunohistochemistry. Immunofluorescence was used to identify NET by co-localization of myeloperoxidase (MPO) and citrullinated histone H3 (H3Cit). Bivariate statistics, Kaplan-Meier survival analysis, and the log-rank test were performed.
Results: HPV-positive and HPV-negative OP-SCC had similar CD66b + neutrophil infiltration (p > 0.05), but the release of NET was significantly increased in HPV-positive compared to HPV-negative OP-SCC samples (p < 0.05). Overall survival was not impacted by NET indexes (p > 0.05).
Conclusion: The presence of HPV may stimulate NET release in the OP-SCC microenvironment.
Keywords: neutrophil extracellular traps; oropharyngeal squamous cell carcinoma; oropharynx; squamous cell carcinoma.
© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
-
- T. A. Berman and J. T. Schiller, “Human Papillomavirus in Cervical Cancer and Oropharyngeal Cancer: One Cause, Two Diseases,” Cancer 123, no. 12 (2017): 2219–2229, https://doi.org/10.1002/cncr.30588.
-
- H. Sung, J. Ferlay, R. L. Siegel, et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 71, no. 3 (2021): 209–249, https://doi.org/10.3322/caac.21660.
-
- S. Al‐Sahaf, N. B. Hendawi, B. Ollington, et al., “Increased Abundance of Tumour‐Associated Neutrophils in HPV‐Negative Compared to HPV‐Positive Oropharyngeal Squamous Cell Carcinoma Is Mediated by IL‐1R Signalling,” Frontiers in Oral Health 2 (2021): 604565, https://doi.org/10.3389/froh.2021.604565.
-
- S. Marur, G. D'Souza, W. H. Westra, and A. A. Forastiere, “HPV‐Associated Head and Neck Cancer: A Virus‐Related Cancer Epidemic,” Lancet Oncology 11, no. 8 (2010): 781–789, https://doi.org/10.1016/S1470‐2045(10)70017‐6.
-
- S. Partlová, J. Bouček, K. Kloudová, et al., “Distinct Patterns of Intratumoral Immune Cell Infiltrates in Patients With HPV‐Associated Compared to Non‐virally Induced Head and Neck Squamous Cell Carcinoma,” Oncoimmunology 4, no. 1 (2015): e965570, https://doi.org/10.4161/21624011.2014.965570.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
